Robert B. Bazemore Jr
2018
In 2018, Robert B. Bazemore Jr earned a total compensation of $3.7M as President and Chief Executive Officer at Epizyme, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,575 |
|---|---|
| Option Awards | $2,748,939 |
| Salary | $575,667 |
| Other | $5,690 |
| Total | $3,650,871 |
Bazemore received $2.7M in option awards, accounting for 75% of the total pay in 2018.
Bazemore also received $320.6K in non-equity incentive plan, $575.7K in salary and $5.7K in other compensation.
Rankings
In 2018, Robert B. Bazemore Jr's compensation ranked 3,095th out of 14,244 executives tracked by ExecPay. In other words, Bazemore earned more than 78.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,095 out of 14,244 | 78th |
Division Manufacturing | 1,148 out of 5,759 | 80th |
Major group Chemicals And Allied Products | 398 out of 2,122 | 81st |
Industry group Drugs | 327 out of 1,811 | 82nd |
Industry Pharmaceutical Preparations | 250 out of 1,385 | 82nd |
Source: SEC filing on April 18, 2019.
Bazemore's colleagues
We found four more compensation records of executives who worked with Robert B. Bazemore Jr at Epizyme in 2018.